Cargando…

Modulating effects of RAMPs on signaling profiles of the glucagon receptor family

Receptor activity-modulating proteins (RAMPs) are accessory molecules that form complexes with specific G protein-coupled receptors (GPCRs) and modulate their functions. It is established that RAMP interacts with the glucagon receptor family of GPCRs but the underlying mechanism is poorly understood...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shao, Lijun, Chen, Yan, Zhang, Shikai, Zhang, Zhihui, Cao, Yongbing, Yang, Dehua, Wang, Ming-Wei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8897147/ https://www.ncbi.nlm.nih.gov/pubmed/35256936 http://dx.doi.org/10.1016/j.apsb.2021.07.028

Ejemplares similares

RAMP2 Influences Glucagon Receptor Pharmacology via Trafficking and Signaling
por: Cegla, Jaimini, et al.
Publicado: (2017)

Modulation of Glucagon Receptor Pharmacology by Receptor Activity-modifying Protein-2 (RAMP2)
por: Weston, Cathryn, et al.
Publicado: (2015)

Receptor Activity-Modifying Protein 2 (RAMP2) alters glucagon receptor trafficking in hepatocytes with functional effects on receptor signalling
por: McGlone, Emma Rose, et al.
Publicado: (2021)

The putative signal peptide of glucagon-like peptide-1 receptor is not required for receptor synthesis but promotes receptor expression
por: Ge, Yunjun, et al.
Publicado: (2014)

Modulation of β-Catenin Signaling by Glucagon Receptor Activation
por: Ke, Jiyuan, et al.
Publicado: (2012)

Glucagon Receptor Signaling and Glucagon Resistance
por: Janah, Lina, et al.
Publicado: (2019)

Molecular insights into ago-allosteric modulation of the human glucagon-like peptide-1 receptor
por: Cong, Zhaotong, et al.
Publicado: (2021)

Hepatocyte cholesterol content modulates glucagon receptor signalling
por: McGlone, Emma Rose, et al.
Publicado: (2022)

Calcitonin/Amylin Receptors and Ramps
por: Sexton, Patrick M.
Publicado: (2001)

Functional modulation of PTH1R activation and signaling by RAMP2
por: Nemec, Katarina, et al.
Publicado: (2022)

Glucagon Receptor Signaling and Lipid Metabolism
por: Galsgaard, Katrine D., et al.
Publicado: (2019)

Cardiomyocyte glucagon receptor signaling modulates outcomes in mice with experimental myocardial infarction
por: Ali, Safina, et al.
Publicado: (2014)

Conformational states of the full-length glucagon receptor
por: Yang, Linlin, et al.
Publicado: (2015)

3rd Expert Consultation on RAMP : RAMP-III
Publicado: (1986)

Ramping '97
por: Jonker, M
Publicado: (1998)

Orbit in the ramp
por: Wenninger, J
Publicado: (1998)

Accumulation and ramping
por: Brüning, Oliver Sim
Publicado: (2000)

Ramping and snapback
por: Butterworth, A
Publicado: (2005)

Development of chimeric and bifunctional antagonists for CLR/RAMP receptors
por: Chang, Chia Lin, et al.
Publicado: (2019)

A unique hormonal recognition feature of the human glucagon-like peptide-2 receptor
por: Sun, Wen, et al.
Publicado: (2020)

Structural insights into multiplexed pharmacological actions of tirzepatide and peptide 20 at the GIP, GLP-1 or glucagon receptors
por: Zhao, Fenghui, et al.
Publicado: (2022)

The ubiquitination status of the glucagon receptor determines signal bias
por: Kaur, Suneet, et al.
Publicado: (2023)

Evaluation of commercially available glucagon receptor antibodies and glucagon receptor expression
por: Bomholt, Anna Billeschou, et al.
Publicado: (2022)

Intensity ramp-up
por: Lamont, M
Publicado: (2010)

Energy ramping in LEP
por: Ciapala, Edmond, et al.
Publicado: (1990)

Injection and ramping: Discussion
por: Wenninger, J
Publicado: (1998)

Ramping high intensities
por: Wenninger, J
Publicado: (1997)

Injection and ramping summary
por: Lamont, M, et al.
Publicado: (1997)

Ramping High Currents
por: Wenninger, J
Publicado: (1999)

Ramp Management in RHIC
por: Kewisch, J, et al.
Publicado: (1999)

Accumulation and Ramping in the LHC
por: Brüning, Oliver Sim
Publicado: (2000)

Ramp: experience and issues
por: Delsolaro, W Venturini
Publicado: (2010)

Ramping activity in the striatum
por: Ponzi, Adam, et al.
Publicado: (2022)

The Glycosphingolipid GM3 Modulates Conformational Dynamics of the Glucagon Receptor
por: Ansell, T. Bertie, et al.
Publicado: (2020)

Modulation of Glucagon Signaling: A Metabolic Approach for Heart Failure?
por: Pocai, Alessandro
Publicado: (2019)

Tail engagement of arrestin at the glucagon receptor
por: Chen, Kun, et al.
Publicado: (2023)

Sustained Activation of CLR/RAMP Receptors by Gel-Forming Agonists
por: Chang, Chia Lin, et al.
Publicado: (2022)

Structural Determinants in the Calcitonin Receptor-Like Receptor (Crlr) Important for Cgrp and Adrenomedullin (Am) Receptor Function of Crlr/Receptor-Activity-Modifying Protein (Ramp) 1 and Crlr/Ramp2 Heterodimers
por: Born, W., et al.
Publicado: (2001)

Disruption of the glucagon receptor increases glucagon expression beyond α-cell hyperplasia in zebrafish
por: Kang, Qi, et al.
Publicado: (2022)

Clinical Outcome of RAMPS for Left-Sided Pancreatic Ductal Adenocarcinoma: A Comparison of Anterior RAMPS versus Posterior RAMPS for Patients without Periadrenal Infiltration
por: Kwon, Jaewoo, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_vvba515j4v5mtao2lte228dp4m